Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan

Nargiza Sultanbayeva, Shakhnoz Umarova, Shokhista Iskandarova, Guzal Mullabaeva, Shohista Mukhamedova

Open source

DOI: 10.2174/011871529x495679261009064725
Published: 2026-10-14
Container: Cardiovascular & Hematological Disorders-Drug Targets
Publisher: Bentham Science Publishers Ltd.
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.2174/011871529x495679261009064725,
  title = {Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan},
  author = {Nargiza Sultanbayeva and Shakhnoz Umarova and Shokhista Iskandarova and Guzal Mullabaeva and Shohista Mukhamedova},
  year = {2026},
  journal = {Cardiovascular \&amp; Hematological Disorders-Drug Targets},
  doi = {10.2174/011871529x495679261009064725},
  url = {https://doi.org/10.2174/011871529x495679261009064725}
}

RIS

TY  - JOUR
TI  - Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan
AU  - Nargiza Sultanbayeva
AU  - Shakhnoz Umarova
AU  - Shokhista Iskandarova
AU  - Guzal Mullabaeva
AU  - Shohista Mukhamedova
PY  - 2026
JO  - Cardiovascular &amp; Hematological Disorders-Drug Targets
DO  - 10.2174/011871529x495679261009064725
UR  - https://doi.org/10.2174/011871529x495679261009064725
ER  -

APA

Sultanbayeva, N., Umarova, S., Iskandarova, S., Mullabaeva, G., & Mukhamedova, S. (2026). Cost-effectiveness of Empagliflozin in Chronic Heart Failure: A Markov Model-based Analysis in Uzbekistan. Cardiovascular & Hematological Disorders-Drug Targets. https://doi.org/10.2174/011871529x495679261009064725

Source records

crossref · retrieved 2026-11-10T18:55:06.328Z